Protease-induced release of functional peptides from bioplexes

Journal of Controlled Release : Official Journal of the Controlled Release Society
M G SvahnL J Brandén

Abstract

Linking peptide functions directly to nucleic acids can be used to improve transfection. We have previously demonstrated this by sequence-specific hybridization of a bifunctional peptide nucleic acid (PNA) consisting of a nucleic acid binding moiety conjugated to a peptide. The resulting biological complex of PNA/DNA is called a Bioplex. The bifunctional PNA is continuously synthesized with one or more functional entities. For certain applications, it might be preferable to eliminate a functional entity after it has served its purpose. We have addressed this issue by adding a specific protease cleavage site to the construct. In this first approach, cathepsin L was used to cleave a linker sequence including a cathepsin L site: afrsaaq, thereby releasing the tri-peptide Arg-Gly-Asp (RGD) from the PNA anchor. In vitro and in vivo experiments showed an efficient cleavage of the peptide. Moreover, bifunctional PNA constructs were shown to retain activity of the second entity following removal of the first function. Since cathepsin L is ubiquitously expressed in eukaryotic cells and becomes active as the endosomal pH drops, inclusion of cathepsin sites makes it possible to remove functional entities in late endosomes/early lysosomes.

References

Oct 23, 1987·Science·E Ruoslahti, M D Pierschbacher
Sep 15, 1994·Biochemical Pharmacology·V V DemidovP E Nielsen
Jan 24, 1998·Biochemical and Biophysical Research Communications·F Tang, J A Hughes
Oct 20, 1998·Nucleic Acids Research·U GiesenP E Nielsen
Jun 8, 2001·The Biochemical Journal·B WetzerD Scherman
Feb 24, 2004·The Journal of Gene Medicine·M G SvahnC I E Smith

❮ Previous
Next ❯

Citations

Jun 3, 2009·Genetica·Karin E LundinC I Edvard Smith
Apr 28, 2007·Oligonucleotides·Mathias G SvahnC I Edvard Smith
Sep 17, 2008·ChemMedChem·Steven R MeyersMark W Grinstaff
Aug 4, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Won Jong KimSung Wan Kim
Jun 1, 2006·Advances in Genetics·Karin E LundinC I Edvard Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.